Published • loading... • Updated
New STEAP1-targeted antibody drug conjugate boosts immune response against
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGNew STEAP1-targeted antibody drug conjugate boosts immune response against
Prostate cancer that stops responding to androgen receptor–targeted therapies remains one of the most lethal challenges in oncology, and a new study from Duke University and Xavier University of Louisiana suggests that the next generation of antibody–drug conjugates may fight this disease in ways that go far beyond simple tumor killing. Published in the Journal […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
